跳至主要内容
临床试验/CTRI/2025/07/091836
CTRI/2025/07/091836尚未招募不适用

RANDOMIZED OPEN LABELED CONTROLLED CLINICAL STUDY OF EFFICACY OF HARIDRADI TAILA MALAHAR PRATISARAN IN VATAJA PITTAJA MUKHPAKA WITH SPECIAL REFERENCE TO ORAL SUBMUCOUS FIBROSIS

Dr Pratibha Kondibarao Waghmare1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2025年8月11日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
100
试验地点
1
主要终点
Improvement in mouth opening

研究概览

简要总结

Oral submucous fibrosis is a Premalignant condition

Satisfactory treatment is unavailable

Trial drug is Haridradi Taila Malahar and Control drug is Daruharidra Rasakriya these Ayurvedic medicines to be locally used as a Pratisaran for Oral submucous fibrosis

Both  experimental and control groups are studied respectively

Observation and conclusions are drawn from statistical test for significance

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patient Selected As Per Diagnostic Criteria Of Oral Submucous Fibrosis.

排除标准

  • Patients Age Below 18 Years And Above 60 Years Suffering From Severe Trismus Interincisal distance of less than 0.5cm Other Inflammatory Conditions of Oral Cavity Such as Candidiasis Herpes stomatitis Oral lichen planus Diphtheria Congenital Maxillofacial deformities Suspected or Diagnosed malignancy Temporomandibular joint disorders Other systemic disease which may cause oral lesion such as TB Uncontrolled diabetes mellitus Severe anemia less than 7 gm per dl Patient suffering from Erythroplakia Patients on immunosuppressant therapy Acute infections or febrile illness Patients not willing to give up habits of chewing gutka tobacco and betel nut.

结局指标

主要结局

Improvement in mouth opening

时间窗: Before Treatment 0 day | After Treatment 31 st day

次要结局

未报告次要终点

研究者

发起方
Dr Pratibha Kondibarao Waghmare
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Pratibha Kondibarao Waghmare

Government Ayurved College and Hospital Nanded

研究点 (1)

Loading locations...

相似试验